GNMX - Aevi Genomic Medicine, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 510.71M
Enterprise Value 38.22M
Trailing P/E N/A
Forward P/E 1-0.26
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)34.00
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.37

Trading Information

Stock Price History

Beta (3Y Monthly) 1.26
52-Week Change 3-86.22%
S&P500 52-Week Change 32.99%
52 Week High 31.3900
52 Week Low 30.1500
50-Day Moving Average 30.1817
200-Day Moving Average 30.1960

Share Statistics

Avg Vol (3 month) 31.68M
Avg Vol (10 day) 3587.67k
Shares Outstanding 564.77M
Float 54.95M
% Held by Insiders 142.43%
% Held by Institutions 119.10%
Shares Short (Aug 15, 2019) 41.09M
Short Ratio (Aug 15, 2019) 40.3
Short % of Float (Aug 15, 2019) 42.62%
Short % of Shares Outstanding (Aug 15, 2019) 41.68%
Shares Short (prior month Jul 15, 2019) 4589.29k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-115.85%
Return on Equity (ttm)-286.25%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -22.43M
Net Income Avi to Common (ttm)-22.36M
Diluted EPS (ttm)-0.3490
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.44M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.09
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-20.84M
Levered Free Cash Flow (ttm)-12.53M